Keith Katkin, Director: Emergent BioSolutions EBS Sell · Filed 25/05/28

Trade details

Type: Insider sale
Amount: $49,417.2
Shares · price: 7,844 sh · $6.30 a share
Held after: 86,431 sh
Stock: Emergent BioSolutions EBS
Person: Keith KatkinDirector
Trade date: 25/05/23
Filed: 25/05/28
Days to filing: 5 days

Sold 8.3% of holdings

Share of holding sold: 8.3%

Emergent BioSolutions trades, last 26 weeks

What else happened in Emergent BioSolutions around then

Filed or reported within 30 days of the trade day · 25/04/23~25/06/22

Keith Katkin's recent trades

Keith KatkinDirector
Sell10b5-1 planEmergent BioSolutions
Sell10b5-1 plan
Emergent BioSolutions
EBS
$128.2K
15,481 sh
$128.2K
Filed 05/04
Traded 04/30
Keith KatkinDirector
Planned sale10b5-1 planEmergent BioSolutions
Planned sale10b5-1 plan
Emergent BioSolutions
EBS
$128.1K
15,481 sh
$128.1K
Filed 04/30
Traded 04/30
Keith KatkinDirector
Planned sale10b5-1 planEmergent BioSolutions
Planned sale10b5-1 plan
Emergent BioSolutions
EBS
$49.4K
7,844 sh
$49.4K
Filed 25/05/23
Traded 25/05/23
Keith KatkinDirector
BuySyndax Pharmaceuticals
Buy
Syndax Pharmaceuticals
SNDX
$91.1K
10,000 sh
$91.1K
Filed 25/05/19
Traded 25/05/19

Keith Katkin, Director — sold $49.4K of Emergent BioSolutions EBS · 8.3% of holdings · 10b5-1 plan | Whalegun